Fact based stock research
Aetna (NYSE:AET)


Aetna stock research in summary

aetna.com


Aetna shares have a SELL rating. While they show above average growth, they are riskily financed, and are bad value. We recommend selling Aetna shares.


Latest Obermatt Ranks


Country USA
Industry Managed Health Care
Index S&P 500, D.J. US Health Care
Size class XX-Large

March 22, 2018. Top 10 stocks updated on Top 10 schedule or at least quarterly. ()


Achievements

Top 10 Stock



Research History: Aetna

STOCK RESEARCH SUMMARY 2015 2016 2017 2018
STOCK VALUE RANKS
30
14
6
10
STOCK GROWTH RANKS
74
68
55
55
STOCK SAFETY RANKS
50
74
50
42
COMBINED STOCK RANKS
48
51
1
19

Last update of Combined Rank: 22-Mar-2018. Stock research history is based on the Obermatt Method. The higher the rank, the better is Aetna in the corresponding investment strategy.


Value Metrics in Detail

Last update of Value Rank: 22-Mar-2018. Stock analysis on value ratios: The higher the rank, the lower the value ratio of Aetna; except for dividend yield where the rank is higher, the higher the yield.


Growth Metrics in Detail

GROWTH METRICS 2015 2016 2017 2018
REVENUE GROWTH
54
44
14
15
PROFIT GROWTH
20
20
20
46
STOCK RETURNS
83
60
92
92
CONSOLIDATED RANK: GROWTH
74
68
55
55

Financial reporting date of Growth Rank: 31-Dec-2017. Stock analysis on growth metrics: The higher the rank, the higher the growth and returns of Aetna.


Safety Metrics in Detail

SAFETY METRICS 2015 2016 2017 2018
LEVERAGE
46
66
50
50
REFINANCING
48
48
37
34
LIQUIDITY
58
72
56
56
CONSOLIDATED RANK: SAFETY
50
74
50
42

Financial reporting date of Safety Rank: 31-Dec-2017. Stock analysis on safety metrics: The higher the rank, the lower the leverage of Aetna and the more cash is available to service its debt.


Stock analysis by the purely financial fact-based Obermatt Method for the investment strategies Value, Growth and Safety for Aetna from March 22, 2018.